These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34681768)

  • 1. NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression.
    Scuderi SA; Casili G; Basilotta R; Lanza M; Filippone A; Raciti G; Puliafito I; Colarossi L; Esposito E; Paterniti I
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
    Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
    J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
    Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D
    Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NLRP3 inflammasome attenuates spinal cord injury-induced lung injury in mice.
    Jiang W; Li M; He F; Zhu L
    J Cell Physiol; 2019 May; 234(5):6012-6022. PubMed ID: 30589073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
    Yang M; Luo Q; Chen X; Chen F
    J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling the Significance of NLRP3 and IL-β1 in Oral Squamous Cell Carcinoma and Potentially Malignant Oral Disorders: A Diagnostic and Prognostic Exploration.
    Jain T; Chandra A; Mishra SP; Khairnar M; Rajoria S; Maheswari R; Keerthika R; Tiwari S; Agrawal R
    Head Neck Pathol; 2024 Aug; 18(1):77. PubMed ID: 39141262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activity of Bacopa monnieri through apoptosis induction and mitophagy-dependent NLRP3 inflammasome inhibition in oral squamous cell carcinoma.
    Mishra SR; Behera BP; Singh VK; Mahapatra KK; Mundkinajeddu D; Bhat D; Minz AM; Sethi G; Efferth T; Das S; Bhutia SK
    Phytomedicine; 2024 Jan; 123():155157. PubMed ID: 37951147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of NLRP3 inflammasome promotes the proliferation and migration of esophageal squamous cell carcinoma.
    Yu S; Yin JJ; Miao JX; Li SG; Huang CZ; Huang N; Fan TL; Li XN; Wang YH; Han SN; Zhang LR
    Oncol Rep; 2020 Apr; 43(4):1113-1124. PubMed ID: 32323780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
    Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
    Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice.
    Jiang W; Li M; He F; Zhou S; Zhu L
    J Neuroinflammation; 2017 Oct; 14(1):207. PubMed ID: 29070054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.
    Nalbandian A; Khan AA; Srivastava R; Llewellyn KJ; Tan B; Shukr N; Fazli Y; Kimonis VE; BenMohamed L
    Inflammation; 2017 Feb; 40(1):21-41. PubMed ID: 27730320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
    Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
    J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
    Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
    J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
    Zhang W; Ba G; Tang R; Li M; Lin H
    Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
    Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
    Li P; Liu Y; He Q
    Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice.
    Bitto A; Altavilla D; Pizzino G; Irrera N; Pallio G; Colonna MR; Squadrito F
    Br J Pharmacol; 2014 May; 171(9):2300-7. PubMed ID: 24329484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.